Send me a link:

*Only U.S. numbers are accepted. Text messaging rates may apply.

 Dow Down 0.10% Nasdaq Up 0.23%
Streaming
Ticker Tape: On

More On CANF

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

Can-Fite BioPharma Ltd. (CANF)

-NYSE MKT
5.31 Up 0.08(1.53%) Apr 17, 4:00PM EDT
Get the big picture on all your investments.
Prev Close:5.23
Open:5.16
Bid:5.22 x 1500
Ask:6.39 x 300
1y Target Est:28.00
Beta:1.184
Next Earnings Date:N/A
Day's Range:5.16 - 5.59
52wk Range:3.30 - 9.46
Volume:15,976
Avg Vol (3m):23,960
Market Cap:36.04M
P/E (ttm):N/A
EPS (ttm):-1.06
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for CANF

Reports

  • No Reports available for CANF at this time.

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-13) :-0.72
Quarterly EPS Est (Dec-13) :-0.21
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Can-Fite BioPharma, Ltd., a clinical-stage biotechnology company, develops small molecule therapeutic products for the treatment of autoimmune-inflammatory, oncological, and ophthalmic diseases. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback